Gide, counsel to iBionext on setting up their management company and structuring their new fund model
16 September 2016
Deals | France | M&A, Regulatory & Fund Structuring
Gide has advised iBionext on setting up their management company and on structuring their first venture capital fund iBionext Growth Fund, which specialises in the investment in and development of innovative healthcare startups. iBionext Growth Fund has announced a first closing of USD 52.5 million, with a target of USD 112 million for 2017. This first fund has drawn interest from international investors, insurance companies and family offices, alongside the Biotech & Healthcare Acceleration Fund (FABS) operated by Bpifrance in the context of the Investments for the Future Program (PIA) managed by General Commissariat for Investment.
Gide’s team comprised partner Christophe Eck on corporate aspects, and counsel Rima Maîtrehenry on regulatory and fund structuring aspects.